23002, 2023 Virtual Mark Allen Everett, MD, Skin of Color Symposium, 2023_05_05

Friday, May 5, 2023, 7:00 AM - 3:00 PM

The 2023 Virtual Mark Allen Everett, MD, Skin of Color Symposium will be presented virtually by the OU COM Department of Dermatology on Friday, May 5, 2023.

This one-day symposium will feature multiple national dermatology experts in skin of color, as well as other professional speakers selected for their knowledge and commitment to diversity in medical education and healthcare. The purpose of the symposium is to(1) increase the knowledge of its attendees, both medical and non-medical, regarding skin of color condition and (2) increase the awareness of diversity gaps and cultural competence in the field of medicine.

Overall Professional Practice Gaps
Gap 1: Healthcare providers may not have the competence, skills, or possess cultural humility to properly treat dermatologic conditions in skin of color patients, which can affect the proper management and overall health.

Gap 2: Healthcare providers may lack the competence and skills to address the biases that affect healthcare disparities and improve health outcomes of patients of color.

Overall Learning Objectives
Upon completion of this Course, participants will improve their competence and performance by being
able to:
1. Prepare physicians, advanced practice providers, students, medical trainees, aestheticians, and hair
care specialists to recognize the unique dermatologic features of skin of color.
2. Assemble a forum to exchange valuable information regarding medical, surgical, and cosmetic
dermatologic conditions of skin of color.
3. Examine cultural competence and bias as it relates to dermatology and the field of medicine at large.
4. Recognize national experts in the field of dermatology.

1. Prepare physicians, advanced practice providers, students, medical trainees, aestheticians, and hair care specialists to recognize the unique dermatologic features of skin of color.
2. Assemble a forum to exchange valuable information regarding medical, surgical, and cosmetic dermatologic conditions of skin of color.
3. Examine cultural competence and bias as it relates to dermatology and the field of medicine at large.
4. Recognize national experts in the field of dermatology.

Active OU/VA/OMRF – Providers, Faculty, & Staff
Early Registration Fee: $75.00
Late/Regular Registration Fee: $85.00

Non-OU/VA/OMRF – Providers, Faculty, & Staff
Early Registration Fee: $90.00
Late/Regular Registration Fee: $100.00

OU Alumni
Early Registration Fee: $75.00
Late/Regular Registration Fee: $85.00

Fellows
Free Registration: (Contact Renee Wall at (405) 271-4662 or [email protected] for registration promo code)


Healthcare Students & Residents
Free Registration: (Contact Renee Wall at (405) 271-4662 or [email protected] for registration promo code)


Non-Healthcare Professionals (cosmetologists, barbers, hair stylists, aestheticians, etc.) 
Early Registration Fee: $25.00
Late/Regular Registration Fee: $35.00

ACCME/AMA PRA Accreditation Statement:
The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 6.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education 
ANCC Accreditation Statement: 
OU Medicine, Inc. is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

6.25 CNE contact hours will be awarded for meeting the following criteria: 90% attendance of conference, completion and submission of evaluation form.

This educational activity does not include any content that relates to the products and/or services of a commercial interest that would create a conflict of interest.

Mitigation Statement:
The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable.

University of Oklahoma Equal Opportunity Statement / Non-Discrimination Statement:
The University of Oklahoma, in compliance with all applicable federal and state laws and regulations, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices, or procedures. This includes, but is not limited to: admissions, employment, financial aid, housing, services in educational programs or activities, or health care services that the university operates or provides.

To file a grievance related to the non-discrimination policy, report sexual misconduct, and/or file a formal complaint of sexual misconduct, please utilize the reporting form at ou.edu/reportingform. 

Inquiries regarding non-discrimination policies may be directed to the Office(s) of Institutional Equity as may be applicable - Norman campus: (405) 325-3546/3549, Health Sciences Center: (405) 271-2110, or OU-Tulsa Title IX Office: (918) 660-3107. Additionally, individuals may visit https://www.ou.edu/eoo.

Accommodation Statement:
Accommodations on the basis of disability are available by contacting Renee Wall at (405) 271-6110 ext. 48002 or [email protected] as soon as possible.

Acknowledgement of Commercial and In-Kind Support: Commercial support is financial, or in-kind, contributions given by an ineligible company, which is used to pay all or part of the costs of a CME activity.  An ineligible company is any company whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity received no commercial or in-kind support.

Disclaimer Statement:
Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

Policy on Faculty and Presenters Disclosure: 
It is the policy of the University of Oklahoma College of Medicine that the faculty and presenters identify all financial relationships with ineligible companies relating to the topics of this educational activity, and also disclose discussions of off-label or investigational drugs/devices and/or therapies during their presentation(s).

AMA PRA Category 1 Credits™ (6.25 hours), ANCC Nursing Contact Hours (6.25 hours), Non-Physician Attendance (6.25 hours)

Pamela S. Allen, MD, FAAD – Course Director
Renee Wall – Course Contact
James F. Albertson, MA
Aaminah Azhar, MD
Carol L. Davenport, MSN, RN-BC, NPD-BC
Myrna Rae Page, MPH, CHES
Tanya Smith, BA

Mitigation of Relevant Financial Relationships

The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable.

Friday, May 5, 2023

Acknowledgement of Commercial and In-Kind Support: Commercial support is financial, or in-kind, contributions given by an ineligible company, which is used to pay all or part of the costs of a CME activity.  An ineligible company is any company whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

This activity received no commercial or in-kind support.